ARTICLES ON VALVULOPATHIES
Degenerative mitral regurgitation surgery: presentation and outcomes by sex
A retrospective single-center analysis of preoperative status and surgical outcomes in men versus women for all patients undergoing surgery for degenerative mitral regurgitation over 9 years.
Results Following Valve Surgery in Patients with Infective Endocarditis and Preoperative Septic Cerebral Embolism: Insights from the CAMPAIGN Registry
The German CAMPAIGN registry outcomes focused on comparing morbidity and mortality in patients with infective endocarditis (IE) complicated by septic cerebral embolism (SCE) versus those without it.
Mini-Approaches and Sutureless Prostheses… TAVI Is Not the End of Aortic Valve Surgery: Expert Commentary
Commentary by the expert Dr. Elisabet Berastegui on the role of minimally invasive surgery combined with sutureless bioprostheses in the current context.
Reflections on PCI and TAVI in the NOTION 3 Study: The Right to Have Two Diseases, Even in the Heart… and to Have Them Treated
Analysis of the NOTION 3 Study and Its Implications for the Treatment Allocation of Patients with Severe Aortic Stenosis and Concomitant Coronary Artery Disease
When the Aortic Bioprosthesis Degenerates: Revalve or Replace?
This American multicenter retrospective study evaluates the medium-term outcomes of patients with degenerated aortic bioprostheses who underwent either percutaneous valve-in-prosthesis procedures or reoperation for valve replacement.
Spain, 17 countries in one… also in terms of infective endocarditis epidemiology
Epidemiological study on the prevalence and regional differences in etiologies, treatment, and outcomes of infective endocarditis in Spain.
Balloon-Expandable Myval® Bioprosthesis Matches Contemporary Devices: A Surgeon’s Perspective
Randomized Clinical LANDMARK Non-Inferiority Trial Comparing the Meril Myval® Balloon-Expandable Prosthesis with Widely Used Contemporary Prostheses (Edwards SAPIEN® and Medtronic Evolut®) in Transcatheter Aortic Valve Implantation
Biological Aortic Valve Replacement in Young Patients with Bicuspid Aortic Valve: Is It Still a Viable Option?
This article analyzes outcomes from 498 patients under the age of 65 with bicuspid aortic valve (BAV) undergoing aortic valve replacement (AVR) with bioprostheses due to aortic stenosis (AS).
Mitral valve replacement: mechanical versus biological: long-term experience
Long-term follow-up after mitral valve replacement focusing on the impact of biological versus mechanical prostheses on survival and reoperation rates in over 2,000 patients, adjusted using propensity score matching.
Bicuspid Aortic Valve Repair: Importance of Annular and Sinotubular Junction Stabilization
A retrospective, multicenter analysis of outcomes in valve repair for aortic insufficiency caused by bicuspid valvulopathy with or without associated aortopathy, with a follow-up period of 10 years.